X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ANGIOGENESIS

期刊標題檢索 ANGIOGENESIS 最新評論: It has been almost two weeks since I submitted my manuscript. The sta... (2024-05-19)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ANGIOGENESIS]您好,您是該頁面的第 37215 位訪客。

期刊簡介
期刊名稱ANGIOGENESIS ANGIOGENESIS
LetPub Score
7.7
50 ratings
Rate

Reputation
8.7

Influence
7.0

Speed
6.9

期刊簡稱ANGIOGENESIS
ISSN0969-6970
E-ISSN1573-7209
h-index80
CiteScore
CiteScoreSJRSNIPCiteScore Rank
21.903.2891.698
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Clinical Biochemistry
Q11 / 117
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Physiology
Q16 / 193
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q114 / 230

自引率 (2023-2024)12.00%自引率趨勢
掲載範囲
Angiogenesis is an international peer-reviewed journal devoted to the publication of top quality original articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis in physiological and pathological conditions. As a central source for rapid communications representing the full spectrum of angiogenesis research, this multidisciplinary journal publishes innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases. Angiogenesis also reports on novel therapeutic approaches for promoting or inhibiting angiogenesis as well as new markers and techniques for disease diagnosis and prognosis.
官方網站https://www.springer.com/10456
在線稿件提交https://www.editorialmanager.com/agen
開放訪問No
出版商Springer Netherlands
主題領域PERIPHERAL VASCULAR DISEASE
出版國/地區NETHERLANDS
發行頻率四半期刊行
創刊年1997
每年文章數27每年文章數趨勢
黃金OA百分比56.48%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PERIPHERAL VASCULAR DISEASESCIEQ13/96
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0969-6970%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【ANGIOGENESIS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640861
    BIOMATERIALS571712
    BIOMEDICINE & PHARMACOTHERAPY498355
    Frontiers in Pharmacology486956
    JOURNAL OF ETHNOPHARMACOLOGY478640
    Journal of Materials Chemistry B476062
    Frontiers in Immunology457942
    COLLOIDS AND SURFACES B-BIOINTERFACES419239
    COMPUTERS IN BIOLOGY AND MEDICINE416449
    Frontiers in Oncology413458
  •  

    ANGIOGENESIS ANGIOGENESIS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [ANGIOGENESIS] 的評論撰寫評論
作者: 寂灭湘灵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-19 16:55:24 評論於
It has been almost two weeks since I submitted my manuscript. The status is peer review, so does it mean it's under review?
(0) 讚! | 寂灭湘灵

作者: 水桥金钟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-02 17:18:20 評論於
It's been three days since I submitted my article and it's already showing as under peer review. Is it still in the hands of the editor?
(0) 讚! | 水桥金钟

作者: 空灵紫玉


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2023-10-15 18:59:13 評論於
A bit confused about the situation. Submitted on the 29th, entered peer review on the 3rd, rejected on the 15th, but no feedback was provided
(0) 讚! | 空灵紫玉

作者: 小怪兽123488


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2022-04-09 20:59:32 評論於
The submission took one week to reach the editor's hands, and it took the editor 16 days to decide whether to send it for review or reject it. It is indeed a bit slow.

Editorial decision: Reject without review
On 09 Apr, 2022

Editor assigned
On 24 Mar, 2022

First submitted to Angiogenesis
On 18 Mar, 2022
(1) 讚! | 小怪兽123488

作者: 气甲可昕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-07 12:56:49 評論於
It takes one week for the submission to reach the editor. The editor then has 16 days to decide whether to send it for review or reject it, which is a bit slow
(0) 讚! | 气甲可昕

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:25:21 評論於
Authors need to objectively assess whether the quality of their research work matches the level of the selected journal. Top journals have high requirements for the originality of manuscripts. The acceptance rate of top journals like Nature is less than 10%, with the majority of manuscripts being rejected at the editorial level
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:14:46 評論於
Please translate the following paragraph into English and Japanese, and label them as ":" and ":"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 16:07:30 評論於
How many suitable alternative journals are generally chosen for each journal gradient?
(0) 讚! | 北国博达

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 13:51:17 評論於
Can I submit my research directly to top journals like Nature or Science? Will they provide feedback?
(0) 讚! | 平原文波

作者: 是陶然吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-26 21:58:31 評論於
In 2019, I thought my article was a 5 out of 10, which was fairly good. Looking back at previous years' articles, I felt that I was more than prepared. Coming into 2020, I gave it a 9 out of 10, because the direction was more aligned (researching angiogenesis regulation functions of protein, with animal models). So I still had confidence (at least enough to submit for review). However, the template rejected the submission, without even sending it for review!
(0) 讚! | 是陶然吖

作者: 龙鳞昭懿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-10 09:32:44 評論於
How? Has anyone submitted this magazine? It has been in the hands of the editor for a week, why hasn't it been reviewed yet? If you want to reject it, do it quickly
(0) 讚! | 龙鳞昭懿

作者: 璃沙子丹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-15 21:05:58 評論於
How are you? It's been over a month, any news?
(0) 讚! | 璃沙子丹

作者: 魔都琛瑞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-02 10:06:46 評論於
Has anyone submitted this magazine before? It has been with the editor for a week, why hasn't it been sent for review yet? If you want to reject it, please do it quickly
(0) 讚! | 魔都琛瑞

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 15:48:09 評論於
Passing the 5-point mark is worth celebrating. Next year, we will aim higher. Passing the 6-point mark will be even more special
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-08-18 20:16:05 評論於
Got it wrong, I think it's around 7 points
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [ANGIOGENESIS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*